Biktarvy

Biktarvy is a combination medication used in the treatment of HIV-1 infection. It contains emtricitabine, tenofovir alafenamide, and bictegravir, offering a convenient once-daily oral option for managing HIV.

Biktarvy is primarily used for the treatment of HIV-1 infection in adults and children weighing at least 25 kg. This medication is designed to help control HIV infection by lowering the amount of virus in the body, which may help improve the immune system. It is often used as a part of a comprehensive treatment plan that includes other medications and lifestyle changes.

Common effects of Biktarvy may include nausea, diarrhea, and headache. Some individuals may also experience fatigue or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Biktarvy should be handled with care, especially for individuals with kidney problems or bone diseases. It is important to follow the prescribed dosage and not to share this medication with others. Regular monitoring and follow-up with a healthcare provider are recommended to ensure the medication's effectiveness and safety.

Biktarvy may interact with other medications, including certain antibiotics, antifungals, and seizure medications. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be moderated while using Biktarvy.